James Bylund - Aug 3, 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Chief Operating Officer
Signature
/s/ Kimberly Brown (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Aug 3, 2022
Transactions value $
-$292,140
Form type
4
Date filed
8/4/2022, 04:32 PM
Previous filing
Apr 4, 2022
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $189K +2K +20.55% $94.33 11.7K Aug 3, 2022 Direct
transaction RGEN Common Stock Sale -$481K -2K -17.05% $240.40 9.73K Aug 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 -2K -20% $0.00 8K Aug 3, 2022 Common Stock 2K $94.33 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 $240.40 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.36 to $240.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 4,000 of the shares underlying the option have vested. The remaining shares vest as follows: 2,000 shares on April 1, 2023, April 1, 2024 and April 1, 2025.